Abiopharma

New Form 8-K - Neuraxis, INC Filed: 2025-09-02 AccNo: 0001641172-25-026158 Size: 548 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits